Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Idursulfase safety study in young children with Hunter syndrome
2007-006044-22Phase 4Completed
- Sponsor
- Takeda
- Start
- Apr 2008
- Modality
- Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of idursulfase in mucopolysaccharidosis type 2, sponsored by Takeda. Primary endpoint: Safety. Started Apr 2008; status: completed.
02
Drugs
idursulfase
03
Conditions
mucopolysaccharidosis type 2
Beyond the preview
Go deeper on 2007-006044-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-006044-22.